Srivastava Sapna — SEC Form 4 filings
SEC reporting owner CIK 1569226. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-06-07 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nuvalent, Inc. (NUVL) | Director | 4 | — | — | 12 |
| ALUMIS INC. (ALMS) | Director | 3 | — | — | 8 |
| Aura Biosciences, Inc. (AURA) | Director | 3 | — | — | 6 |
| Tourmaline Bio, Inc. (TRML) | Director | 3 | — | — | 6 |
| Innoviva, Inc. (INVA) | Director | 1 | — | — | 2 |
Form 4 filings — Srivastava Sapna
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | Nuvalent, Inc. (NUVL) | Code (U): 5,146 @ $124 · Disposition to issuer (D): 3,444 · Disposition to issuer (D): 68,500 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 3,789 (derivative) · +1 more | EDGAR |
| 2026-07-02 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 3,553 @ $0 · Grant/award (A): 15,528 (derivative) @ $0 | EDGAR |
| 2026-06-18 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 3,444 @ $0 | EDGAR |
| 2026-06-15 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-10-28 | 4 | Tourmaline Bio, Inc. (TRML) | Code (U): 518 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 16,800 (derivative) | EDGAR |
| 2025-08-01 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 49,800 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 2,647 @ $0 · Grant/award (A): 4,147 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 13,000 @ $0 · Grant/award (A): 17,000 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Tourmaline Bio, Inc. (TRML) | Grant/award (A): 16,800 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | ALUMIS INC. (ALMS) | Grant/award (A): 28,877 (derivative) @ $0 · Disposition to issuer (D): 28,877 (derivative) @ $0 · Grant/award (A): 28,877 (derivative) @ $0 · Disposition to issuer (D): 29,946 (derivative) @ $0 · Grant/award (A): 29,946 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Aura Biosciences, Inc. (AURA) | Grant/award (A): 10,500 @ $0 · Grant/award (A): 14,500 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Innoviva, Inc. (INVA) | Grant/award (A): 13,923 @ $0 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 2,499 @ $0 · Grant/award (A): 3,789 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Tourmaline Bio, Inc. (TRML) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1569226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →